Acquired Company
Amgen acquired Five Prime Therapeutics on 4/16/2021 for $38.00 per share in cash, representing an equity value of approximately $1.9 billion.
Show more
111 Oyster Point Blvd, California, 94080-1910, US
Start AI Chat
Market Cap
0.00
52 Wk Range
$N/A - $N/A
Previous Close
$38.00
Open
$38.00
Volume
N/A
Day Range
$38.00 - $38.00
Enterprise Value
0.00
Cash
0.00
Avg Qtr Burn
N/A
Insider Ownership
0.00%
Institutional Own.
0.00%
Qtr Updated
06/30/24
Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
| Drug & Indication | Stage & Event | Catalyst Date |
|---|